Talking about death with children who have severe malignant disease

The New England Journal of Medicine
Ulrika KreicbergsGunnar Steineck

Abstract

One of the questions faced by the parents of a child who is terminally ill with a malignant disease is whether or not they should talk about death with their child. In 2001, we attempted to contact all parents in Sweden who had lost a child to cancer between 1992 and 1997. Among 561 eligible parents, 449 answered a questionnaire, and 429 stated whether or not they had talked about death with their child. None of the 147 parents who talked with their child about death regretted it. In contrast, 69 of 258 parents (27 percent) who did not talk with their child about death regretted not having done so. Parents who sensed that their child was aware of his or her imminent death were more likely to regret not having talked about it (47 percent, as compared with 13 percent of parents who did not sense this awareness in their child; relative risk, 3.7; 95 percent confidence interval, 2.3 to 6.0). The same variable was related to having talked about death (50 percent vs. 13 percent; relative risk, 3.8; 95 percent confidence interval, 2.6 to 5.6), as was being religious (42 percent vs. 25 percent; relative risk, 1.7; 95 percent confidence interval, 1.2 to 2.3). The child's age was related to both having talked about death and the parents'...Continue Reading

References

Apr 1, 1974·Psychological Bulletin·J J Spinetta
Mar 1, 1981·Acta paediatrica Scandinavica·G Raimbault
Sep 1, 1981·Journal of Pediatric Psychology·J J SpinettaJ P Sheposh
Jul 1, 1993·Pediatric Hematology and Oncology·A Goldman, D Christie
May 6, 1999·The New England Journal of Medicine·K BergmarkG Steineck
Mar 31, 2000·Medical and Pediatric Oncology·R NitschkeH Huszti
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M HildenJ Chrastek
Jan 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M HildenR J Mayer
Aug 28, 2002·Acta Oncologica·Gunnar SteineckAsgeir Helgason
Sep 13, 2002·The New England Journal of Medicine·Gunnar SteineckUNKNOWN Scandinavian Prostatic Cancer Group Study Number 4
Apr 23, 2004·The New England Journal of Medicine·Bruce P HimelsteinDavid Weissman

❮ Previous
Next ❯

Citations

Jul 6, 2007·Advances in Health Sciences Education : Theory and Practice·Jeannette GoguenRichard Tiberius
Feb 22, 2012·Current Oncology Reports·Claudia L Epelman
Apr 6, 2006·Palliative & Supportive Care·Maru BarreraSylvain Baruchel
Nov 30, 2007·Palliative & Supportive Care·Jennifer L HsiaoLonnie K Zeltzer
Jul 22, 2009·Palliative & Supportive Care·Sebastien MontelCecile Flahault
May 11, 2012·International Journal of Impotence Research·S CarlssonG Steineck
Jan 23, 2013·Nature Reviews. Clinical Oncology·Elisha Waldman, Joanne Wolfe
Jan 7, 2005·The New England Journal of Medicine·Dawn E Davies
Sep 17, 2004·The New England Journal of Medicine·Lawrence Wolfe
Feb 28, 2006·Journal of Palliative Medicine·Pamela S HindsJoanne Wolfe
Oct 17, 2006·Journal of Palliative Medicine·Ann Morstad BoldtBruce P Himelstein
Dec 26, 2006·Journal of Palliative Medicine·Kelly Nicole MichelsonJoel Frader
Jan 25, 2006·Journal of Palliative Medicine·Bruce P Himelstein
Oct 20, 2010·Journal of Palliative Medicine·Maria C McCarthyJohn A Heath
Jan 6, 2012·Journal of Palliative Medicine·René VollenbroichMonika Führer
Jun 29, 2012·Journal of Palliative Medicine·Danielle A Cataudella, Shayna Zelcer
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HauksdóttirG Steineck
Feb 14, 2006·Current Opinion in Pediatrics·Jennifer W Mack, Joanne Wolfe
May 15, 2013·Journal of Pediatric Hematology/oncology·Michelle A FortierLeonard S Sender
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K BergmarkG Steineck
Dec 25, 2009·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Terrah L FosterCynthia A Gerhardt
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott H MaurerJustin N Baker
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melissa K CousinoEric D Kodish
Aug 4, 2011·Indian Journal of Palliative Care·Maryann MuckadenSavita Goswami
Oct 31, 2006·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A Di Gallo, D Bürgin
Jun 7, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Karin Stinesen KollbergGunnar Steineck
Jul 17, 2010·American Journal of Epidemiology·Arna HauksdóttirUnnur Valdimarsdóttir
Apr 6, 2012·European Journal of Pediatrics·Eva Bergstraesser
Dec 5, 2012·European Journal of Pediatrics·Eva BergstraesserRainer Hornung
Jan 15, 2011·Acta Oncologica·Mariët HagedoornCharlotte Appel
Jul 27, 2007·Acta Oncologica·Erik OnelövUnnur Valdimarsdóttir
Jan 23, 2016·Pediatric Blood & Cancer·Joanne Hilden
Dec 25, 2015·Pediatric Blood & Cancer·Meaghann S WeaverPamela S Hinds
Dec 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Niclas PetterssonGunnar Steineck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.